Attitudes toward COVID-19 vaccines among pregnant and recently pregnant individuals. 

JAMA network open. 2024

COVID-19 vaccination in the first trimester and major structural birth defects among live births. 

JAMA pediatrics. 2024

Coronavirus disease 2019 (COVID-19) vaccination and stillbirth in the Vaccine Safety Datalink. 

Obstetrics and Gynecology. 2024

Impact of the COVID-19 pandemic on health care utilization in the Vaccine Safety Datalink: retrospective cohort study. 

JMIR public health and surveillance. 2024

Increased identification of vaccines for vaccine safety surveillance through linkage with the Minnesota Immunization Information Connection as of December 31, 2023. 

Public Health Reports. 2024

Lack of evidence for vaccine-associated enhanced disease from COVID-19 vaccines among adults in the Vaccine Safety Datalink. 

Pharmacoepidemiology and Drug Safety. 2024

Obstetric complications and birth outcomes after antenatal coronavirus disease 2019 (COVID-19) vaccination. 

Obstetrics and Gynecology. 2024

Tinnitus after COVID-19 vaccination: findings from the vaccine adverse event reporting system and the vaccine safety datalink. 

American Journal of Otolaryngology. 2024

A broad assessment of COVID-19 vaccine safety using tree-based data-mining in the vaccine safety datalink. 

Vaccine. 2023

A safety study evaluating non-COVID-19 mortality risk following COVID-19 vaccination. 

Vaccine. 2023

Active postlicensure safety surveillance for recombinant zoster vaccine using electronic health record data. 

American Journal of Epidemiology. 2023

Association between aluminum exposure from vaccines before age 24 months and persistent asthma at age 24 to 59 months. 

Academic Pediatrics. 2023

COVID-19 booster vaccination in early pregnancy and surveillance for spontaneous abortion. 

JAMA network open. 2023

COVID-19 vaccine safety surveillance in early pregnancy in the United States: design factors affecting the association between vaccine and spontaneous abortion. 

American Journal of Epidemiology. 2023

Influenza vaccination coverage among persons ages six months and older in the Vaccine Safety Datalink in the 2017-18 through 2022-23 influenza seasons. 

Vaccine. 2023

Safety of measles, mumps, and rubella vaccine in adolescents and adults in the Vaccine Safety Datalink. 

Vaccine. 2023

Safety of simultaneous vaccination with COVID-19 vaccines in the Vaccine Safety Datalink. 

Vaccine. 2023

Safety signal identification for COVID-19 bivalent booster vaccination using tree-based scan statistics in the Vaccine Safety Datalink. 

Vaccine. 2023

Tree-based data mining for safety assessment of first COVID-19 booster doses in the Vaccine Safety Datalink. 

Vaccine. 2023

Association of the COVID-19 pandemic with routine childhood vaccination rates and proportion up to date with vaccinations across 8 US health systems in the Vaccine Safety Datalink. 

JAMA pediatrics. 2022

Changes in incidence rates of outcomes of interest in vaccine safety studies during the COVID-19 pandemic. 

Vaccine. 2022

Effectiveness of BNT162b2 and mRNA-1273 second doses and boosters for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and SARS-CoV-2-related hospitalizations: a statewide report from the Minnesota Electronic Health Record Consortium. 

Clinical Infectious Diseases. 2022

Evaluation of acute adverse events after Covid-19 vaccination during pregnancy. 

New England Journal of Medicine. 2022

Health care utilization in the 6 months following SARS-CoV-2 infection. 

JAMA network open. 2022

Incidence of Guillain-Barré syndrome after COVID-19 vaccination in the Vaccine Safety Datalink. 

JAMA network open. 2022

Kawasaki disease following the 13-valent pneumococcal conjugate vaccine and rotavirus vaccines. 

Pediatrics. 2022

Monitoring vaccine safety using the Vaccine Safety Datalink: assessing capacity to integrate data from Immunization Information systems. 

Vaccine. 2022

Receipt of COVID-19 vaccine during pregnancy and preterm or small-for-gestational-age at birth - eight integrated health care organizations, United States, December 15, 2020-July 22, 2021. 

MMWR: Morbidity and Mortality Weekly Report. 2022

Risk of myocarditis and pericarditis following BNT162b2 and mRNA-1273 COVID-19 vaccination. 

Vaccine. 2022

Safety of COVID-19 vaccination in United States children ages 5 to 11 years. 

Pediatrics. 2022

Travelers and travel vaccines at six health care systems in the Vaccine Safety Datalink. 

Vaccine. 2022

COVID-19 vaccination coverage among insured persons aged ≥16 years, by race/ethnicity and other selected characteristics - eight integrated health care organizations, United States, December 14, 2020-May 15, 2021. 

MMWR: Morbidity and Mortality Weekly Report. 2021

COVID-19 vaccination coverage among pregnant women during pregnancy - eight integrated health care organizations, United States, December 14, 2020-May 8, 2021. 

MMWR: Morbidity and Mortality Weekly Report. 2021

Incidence of pediatric inflammatory bowel disease within the Vaccine Safety Datalink network and evaluation of association with rotavirus vaccination. 

Vaccine. 2021

Surveillance for adverse events after COVID-19 mRNA vaccination. 

JAMA. 2021

Vaccine Safety Datalink infrastructure enhancements for evaluating the safety of maternal vaccination. 

Therapeutic advances in drug safety. 2021

Evaluating the association of stillbirths after maternal vaccination in the Vaccine Safety Datalink. 

Obstetrics and Gynecology. 2020

SARS-CoV-2 infection among hospitalized pregnant women: reasons for admission and pregnancy characteristics - eight U.S. health care centers, March 1-May 30, 2020. 

MMWR: Morbidity and Mortality Weekly Report. 2020

Uptake and safety of hepatitis A vaccination during pregnancy: a Vaccine Safety Datalink study. 

Vaccine. 2019

Safety of repeated doses of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine in adults and adolescents. 

Pharmacoepidemiology and Drug Safety. 2018

Uptake and safety of Hepatitis B vaccination during pregnancy: a Vaccine Safety Datalink study. 

Vaccine. 2018

Identifying birth defects in automated data sources in the Vaccine Safety Datalink. 

Pharmacoepidemiology and Drug Safety. 2017

Immunization: Vaccine Safety Datalink. 

Minn Physician. 2017

Live attenuated influenza vaccine use and safety in children and adults with asthma. 

Annals of Allergy, Asthma, and Immunology. 2017

Influenza vaccination during pregnancy: influenza seasons 2002-2012, Vaccine Safety Datalink. 

American Journal of Preventive Medicine. 2016

Maternal Tdap vaccination: coverage and acute safety outcomes in the vaccine safety datalink, 2007-2013. 

Vaccine. 2016

Safety of measles-containing vaccines in 1-year-old children. 

Pediatrics. 2015

Safety of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis and influenza vaccinations in pregnancy. 

Obstetrics and Gynecology. 2015

Monovalent H1N1 influenza vaccine safety in pregnant women, risks for acute adverse events. 

Vaccine. 2014

Receipt of pertussis vaccine during pregnancy across 7 Vaccine Safety Datalink Sites. 

Preventive Medicine. 2014

Safety of diphtheria, tetanus, acellular pertussis and inactivated poliovirus (DTaP-IPV) vaccine. 

Vaccine. 2014

Timely versus delayed early childhood vaccination and seizures. 

Pediatrics. 2014

Guillain-Barre syndrome, influenza vaccination, and antecedent respiratory and gastrointestinal infections: a case-centered analysis in the Vaccine Safety Datalink, 2009-2011. 

PloS One. 2013

Identifying pregnancy episodes, outcomes, and mother-infant pairs in the Vaccine Safety Datalink. 

Vaccine. 2013

Maternal safety of trivalent inactivated influenza vaccine in pregnant women. 

Obstetrics and Gynecology. 2013

Risk of adverse events following oseltamivir treatment in influenza outpatients, Vaccine Safety Datalink Project, 2007-2010. 

Pharmacoepidemiology and Drug Safety. 2013

Safety of a tetanus-diphtheria-acellular pertussis vaccine when used off-label in an elderly population. 

Clinical Infectious Diseases. 2013

Safety of the yellow fever vaccine: a retrospective study. 

Journal of Travel Medicine. 2013

Secular trends in diagnostic code density in electronic healthcare data from health care systems in the Vaccine Safety Datalink Project. 

Vaccine. 2013

Trivalent inactivated influenza vaccine and spontaneous abortion. 

Obstetrics and Gynecology. 2013

Vaccination site and risk of local reactions in children 1 through 6 years of age. 

Pediatrics. 2013

Measles-containing vaccines and febrile seizures in children age 4 to 6 years. 

Pediatrics. 2012

Patterns in influenza antiviral medication use before and during the 2009 H1N1 pandemic, Vaccine Safety Datalink Project, 2000-2010. 

Influenza and other respiratory viruses. 2012

Safety of zoster vaccine in adults from a large managed-care cohort: a Vaccine Safety Datalink study. 

Journal of Internal Medicine. 2012

Monitoring vaccine safety using the Vaccine Safety Datalink: utilizing immunization registries for pandemic influenza. 

Vaccine. 2011

Safety of trivalent inactivated influenza vaccine in children aged 24 to 59 months in the vaccine safety datalink. 

Archives of Pediatrics and Adolescent Medicine. 2011

Near real-time surveillance for influenza vaccine safety: proof-of-concept in the Vaccine Safety Datalink Project. 

American Journal of Epidemiology. 2010

Accuracy of data on influenza vaccination status at four Vaccine Safety Datalink sites. 

American Journal of Preventive Medicine. 2009

An assessment of the safety of adolescent and adult tetanus-diphtheria-acellular pertussis (Tdap) vaccine, using active surveillance for adverse events in the Vaccine Safety Datalink. 

Vaccine. 2009

Frequency of medically attended adverse events following tetanus and diphtheria toxoid vaccine in adolescents and young adults: a Vaccine Safety Datalink study. 

BMC Infectious Diseases. 2009

Risk of medically attended local reactions following diphtheria toxoid containing vaccines in adolescents and young adults: a Vaccine Safety Datalink study. 

Vaccine. 2009

Acute adverse events following trivalent inactivated influenza vaccine (TIV) in pregnancy [poster]

2012

Safety of seasonal influenza vaccine (TIV) in pregnant women [poster]

2011

Safety of the yellow fever vaccine: a retrospective study [poster]

2011

Vaccine Safety Datalink (VSD): the dynamic data files (DDF) [poster]

2008

The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety [review]. 

Vaccine. 2014

Assessing the safety of influenza immunization during pregnancy: the Vaccine Safety Datalink [review]. 

American Journal of Obstetrics and Gynecology. 2012

A descriptive study of vaccinations occurring during pregnancy, 2002-2006 [abstract]. 

Clinical Medicine & Research. 2012

Identifying pregnancy episodes in the Vaccine Safety Datalink [abstract]. 

Clinical Medicine & Research. 2012

White paper on the safety of the childhood immunization schedule

2016

Safety of COVID-19 vaccination in pregnancy - interim data from the Vaccine Safety Datalink [presentation], CDC Prevention Advisory Committee on Immunization Practices (ACIP) Meeting

Safety of the seasonal influenza vaccine during pregnancy: maternal health outcomes [presentation], VSD Annual Meeting